Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Development and Characterization of the Patient-Friendly Formulations: Preparation and Characterization of a Suspension Containing Nanoparticulated Rebamipide for Stomatitis

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: HANAWA, Takehisa (Tokyo University of Science, Faculty of Pharmaceutical Sciences, Noda-City, Japan)
  • Co-author(s): Yayoi Kawano: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-City, Japan
    Naoko Ishii: Dept. of Pharmacy, Kashiwa City Hospital, Kashiwa-City, Japan
    Yuichiro Shimizu: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-City, Japan
    Takehisa Hanawa: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-City, Japan
  • Abstract:

    Backgrounds

     Aphthous stomatitis is known to be induced by chemotherapy and radiotherapy. One hundred percent of patients administered high-dose chemotherapy and 80% of patients receiving radiotherapy develop stomatitis. Furthermore, it has been reported that stomatitis is a prominent clinical problem affecting approximately 40% of patients..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses